New Key Statistics Module, Z-Score and F-Score
NAS:CUE Key Ratios
| Market Cap $ M | 65.88 |
| Enterprise Value $ M | 42.03 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.48 |
| Price/Sales | 5.26 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -0.91 |
| Beneish M-Score | -1.86 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 10.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.97 |
| EV-to-EBITDA | -1.05 |
| PEG | -- |
| Shares Outstanding M | 63.35 |
| Net Margin (%) | -468.02 |
| Operating Margin % | -478.79 |
| Pre-tax Margin (%) | -468.02 |
| Quick Ratio | 2.22 |
| Current Ratio | 2.22 |
| ROA % (ttm) | -82.16 |
| ROE % (ttm) | -142.28 |
| ROIC % (ttm) | -234.33 |
| Dividend Yield % | -- |
| Altman Z-Score | -10.85 |
CUE Number of Guru Trades
CUE Volume of Guru Trades
Gurus Latest Trades with NAS:CUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CUE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cue Biopharma Inc Insider Transactions
No Available Data
News about NAS:CUE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers